Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk
Article 2006 en
Authors
DL
Douglas S. Lee
JE
Jane C. Evans
SR
Sander J. Robins
Abstract
1 min read
An increase in serum GGT predicts onset of metabolic syndrome, incident CVD, and death suggesting that GGT is a marker of metabolic and cardiovascular risk.
Kai Ninomiya, Patrick W. Serruys, Shigetaka Kageyama, Nozomi Kotoku, Shinichiro Masuda, Pruthvi Chenniganahosahalli Revaiah, Neil O’Leary, A. Pieter Kappetein, David R. Holmes, Yoshinobu Onuma
Theodora W. Elffers, Renée de Mutsert, Hildo J. Lamb, Arie C. Maan, Peter W. Macfarlane, Ko Willems van Dijk, Frits R. Rosendaal, J. Wouter Jukema, Stella Trompet
Discussion(0)
No comments yet. Be the first to comment.